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Our aim is to explore (1) whether gestational medication use, mode of delivery, and early postnatal exposure correlate with
childhood asthma, (2) the dose responsiveness of such exposure, and (3) their links to early- and late-onset asthma. We conducted
a matched case-control study based on the Taiwan Children Health Study, which was a nationwide survey that recruited 12-to-14-
year-oldschoolchildrenin14communities.579mothersoftheparticipantswereinterviewedbytelephone.Exclusivebreastfeeding
protected children from asthma. Notably, childhood asthma was signiﬁcantly associated with maternal medication use during
pregnancy, vacuum use during vaginal delivery, recurrent respiratory tract infections, hospitalization, main caregiver cared for
other children, and early daycare attendance. Exposure to these factors led to dose responsiveness in relationships to asthma. Most
of the exposures revealed a greater impact on early-onset asthma, except for vacuum use and daycare attendance.
1.Introduction
Asthma is a common childhood disease of complex etiology.
Early-life environmental exposures are critical in determin-
ing susceptibility to asthma and allergic disease. Large epi-
demiological studies suggest that the key time period for the
development of childhood asthma occurs between concep-
tion and 3 years old [1]. Both in utero exposure and early-
life factors play important roles in the development of airway
inﬂammation and hyper responsiveness [2]. The environ-
mental factors that induce atopy may act together to aﬀect
the immune system, which later plays a part in the develop-
ment of childhood wheezing or asthma.
Several prenatal, perinatal, and early postnatal risk fac-
tors have been reported to be related to childhood asthma.
In the prenatal aspect, gestational Acetaminophen use might
increase the risk of asthma [3]. In the perinatal aspect, some
studies have shown that cesarean section causes an increased
risk of asthma, but large population studies did not establish
acleardegreeofconsistency[4].Beingbornatgestationalage
of less than 37 weeks and having a low birth weight are well-
known risks for asthma development [5]. In the early post-
natal risk factors, issues regarding breastfeeding have yielded
inconsistent results due to methodological diﬀerences and
ﬂaws in study design, the immunologic complexity of breast
milk, and the possible genetic diﬀerences among patients
[6]. Even age of daycare attendance might inﬂuence the risk
of asthma [7]. Recurrent respiratory infections during early
childhood also play an important role in asthma incidence
[8]. Although several research papers have focused on envi-
ronmental exposures for childhood asthma, few studies have
discussed the inﬂuence of the timing of exposure and proved
the exposure-asthma relationships in a dose-response man-
ner. On the other hand, based on the background of popular
use of herbal medicine during the pregnancy in Taiwan [9],
we do not ﬁnd any study exploring the relationship between
gestational herbal medication use, and asthma.
Inthepresentstudy,weexploreindetailtherelationships
between early-in-life exposure to environmental factors such
as gestational medication use, birth conditions, breastfeed-
ing, daycare attendance, and recurrent respiratory tract in-
fections and asthma in Taiwanese children. Our aims were to
test (1) whether exposure in the environment to these factors
would elevate the risk of asthma, (2) the dose responsiveness2 Clinical and Developmental Immunology
of such exposure, and (3) their links to early- and late-
onset asthma. We designed a case-control study using data
from our previous Taiwan Children Health Study (TCHS)
cohort.
2. Methods
2.1. Subject Selection. We conducted the present study fo-
cusing on the TCHS population. Details of the TCHS have
already been described [10]. Brieﬂy, the TCHS was a nation-
wide population-based study that recruited 5,804 seventh,
and eighth-grade children from the public schools of 14 Tai-
wanesecommunitiesin2007.Aparentofeachchildprovided
written informed consent and completed a self-administered
questionnaire. Data from the TCHS was considered baseline
data.
A matched sampling design was used to select partici-
pants for this nested case-control study. Our study consisted
of 4,982 of the 5,804 children, who were nonsmoking chil-
dren aged 12 to 14 years old at the time of enrollment in
the TCHS. Based on 3 age groups, 2 genders, and 14 com-
munities, we then divided asthma- and wheeze-free children
into 84 age-, sex-, and community-speciﬁc stratas. Controls
were randomly selected based on a 1:2 principal according
to the number of cases in each stratum. Therefore, our case
group and the control group were matched by age, sex, and
samecommunity.Inastructuredtelephoneinterview,thebi-
ological mothers of the participants were asked to provide
details about their children, including demographics, family
historyofatopicdiseases,gestationalmedicationuse,feeding
practicesininfancy,child’sagewhenstartingdaycareattend-
ance, and episodes of respiratory infection events. Children
unaccompanied by their biological mothers were excluded
from our study population. Three well-trained ﬁeld workers
performed the telephone interviews by using standardized
interview skills. All participants provided informed consent.
The study protocol was approved by the Institutional Review
Board at our university hospital, called the “National Taiwan
University Hospital Research Ethics Committee”, and we
complied with the principles outlined in the Helsinki
Declaration [11].
2.2. Exposure Assessment. With regards to prenatal expo-
sures, we focused on detailed medication use status during
maternal pregnancy, including diﬀerent categories of medi-
cation and herbal medication as well. Medication tablet use
was deﬁned as medications which were prescribed by physi-
cians and was categorized into hypnotics, antisemetics, an-
tibiotics, tocolytic medication, analgesics, and medication
for the common cold or gastrointestinal symptoms. General
herbal medications for pregnant women in Taiwan, such as
Bazhen Tang, Si Wu Tang, Ginseng, Coptis root, and anti-
abortionherbs(An-Tai-Yin)wererecorded.Whenthemoth-
er had a history of taking medication during pregnancy, we
also asked about the time, frequency, and duration of the
medication use.
As to perinatal risks, we were concerned about the modes
of delivery, gestational age at birth and birth weight of the
child. For those from vaginal delivery, we also asked whether
vacuum or forceps were used. Preterm delivery was deﬁned
as birth before 37 weeks in gestational age, and low birth
weight was deﬁned as birth weight lower than 2500gram.
Special peripartum events and congenital defects were also
recorded.
For early postnatal exposures, we gathered information
about breastfeeding, respiratory tract infections, hospitaliza-
tion due to respiratory tract infections and whether or not
the main caregiver cared for other children in the child’s
ﬁrst year of life. We encouraged the mothers to remember
the diagnosis of the respiratory tract infections. Choices of
respiratory tract infections included common cold, sinusitis,
pneumonia, bronchiolitis, croup, acute respiratory distress
syndrome, and unknown etiology. We also asked how early
the child was sent to a daycare center. Upon determining
ever-exposed status, we further inquired about the exposure
duration and frequency, such as duration of exclusive breast-
feeding, and times of respiratory tract infections and hospi-
talizations.
2.3.CaseDeﬁnition. Wedistinguishedasthmacasesandcon-
trols by asking two questions: “Has your child ever experi-
enced diﬃculty breathing, or have you observed any wheez-
ing or whistling from their chest?” and “Has a doctor ever di-
agnosed your child as having asthma?” If the answers were
“Yes”tobothquestions,weconsideredthechildasanasthma
case. If the answers were “No” to both questions, we consid-
ered the child as a control subject. We excluded those with
inconsistent data to avoid information bias. Among the orig-
inal 369 physician diagnosed asthma cases from our cohort,
287caseswereconﬁrmedwith“yes”tobothquestionsduring
our telephone interview. We classiﬁed the age of onset as
early onset (3 years old and below) and late-onset (after 3
years old) in order to reach similar numbers of participants
in each group.
2.4. Statistical Analysis. For our matched case-control study
design, we used conditional logistic regression to assess the
risk of childhood asthma for each individual type of expo-
sure. Odds ratios (ORs) and 95% conﬁdence intervals repre-
sented the eﬀects of each risk factor on developing childhood
asthma. We further analyzed the diﬀerent types of asthma by
deﬁning the asthma as early onset and late onset. ORs for the
association of such exposures with early-onset and late-onset
asthma were computed using the conditional likelihood
method for multinomial logistic regression models. Chi-
squared test of linear trend has been done to present the dose
responsiveness. The missing information among these par-
ticipants was also included in the model by using missing
indicators [12]. Besides some a priori confounders based on
previous research, we included a covariate if the estimate
eﬀects changed by at least 10% in confounder selection.
All of the models were adjusted for the parents’ level of
education, family history of asthma, family history of atopy,
mother’s age at birth of this child, and in utero exposure to
maternal smoking. Family history included the past atopy
or asthma history of the parents. An independent T test was
usedtocalculatethediﬀerenceofmother’sageatbirthofthis
child between cases and controls. All tests were two-sided atClinical and Developmental Immunology 3
Table 1: Demographic characteristics of the study population.
Case Control Control frequency corrected for sampling
(N = 193) (N = 386) (N = 4312)
Characteristics N % N % N‡ %
Sex
Girls 84 43.5 168 43.5 1876 43.5
Boys 109 56.5 218 56.5 2436 56.5
Parental education, yr†
12 116 61.7 264 69.1 2603 60.4
13∼15 41 21.8 69 18.1 888 20.6
16 31 16.5 49 12.8 821 19.0
Family history of asthma†
No 165 89.2 372 97.9 4212 97.7
Yes 20 10.8 8 2.1 100 2.3
Family history of atopy∗†
No 101 54.6 274 72.1 3252 75.4
Yes 84 45.4 106 27.9 1060 24.6
In utero maternal smoking†
No 189 97.9 382 99.0 4162 96.5
Yes 4 2.1 4 1.0 150 3.5
∗Atopy is deﬁned as allergic rhinitis or atopic eczema.
†Number of subjects does not add up to total N because of missing data.
‡Predicted number of controls in the TCHS cohort based on the sampling.
a 5% signiﬁcance level, and our study participant number
was suﬃcient to reach 80% power. We used SAS version 9.1
(SAS Institute, Cary, NC, USA) software for our statistical
analyses.
3. Results
Table 1 showed the demographic characteristics for all asth-
ma cases and controls. Ultimately, 579 mothers were re-
cruited in our study. 67.2% of the biological mothers of
the 287 asthma cases in TCHS completely responded to our
telephone interview. Of the 193 asthma cases, 91 (47.2%)
were deﬁned as early-onset and 102 (52.8%) were deﬁned as
late-onset asthma. We noticed that our control and original
population were of similar frequency in sex, family history of
asthma, and atopy (see Table S2 in supplementary material
available online at doi:10.1155/2012/913426). The propor-
tions of participants with a positive family history of asthma
were 10.8% of asthma cases and 2.1% of the controls
(Table 1). Similarly, asthma children had a higher probability
of a family history of atopy (45.4%) than the control subjects
(27.9%). The average age for the mother at birth of this child
was 26.9 in case group and 28.4 in the control group (P =
0.01). For asthma children, 2.1% experienced in utero expo-
sure to maternal smoking, while only 1.0% of the healthy
group had been exposed to maternal smoking during the
mother’s pregnancy. This case-control study could represent
the original cohort as we compared the frequency of control
group to the control frequency corrected for sampling of
the original population. Besides, our cases and original cases
were of similar frequency in sex, family history of asthma,
and atopy, and in utero maternal smoking (Table S3).
Exposure to medication or herbal medication during
maternalpregnancywaspositivelyassociatedwithchildhood
asthma (Table 2). 18.9% of mothers among our participants
had taken some kinds of medication tablets during their
pregnancy. Among those taking medication, nearly two-
thirds were medication tablets for the common cold. Any
medication tablet use was associated with an increased odds
of asthma (OR = 3.73; 95% CI, 2.2–6.33). Dose responsive-
ness on exposure duration was all signiﬁcant (P for trend
<0.05). The odds of asthma increased up to six times com-
paring to nonexposed group when the exposure occurred
during the ﬁrst trimester (Table 2). Taking medications for
the common cold correlated with asthma positively (OR =
4.35;95%CI,2.28–8.3).Theeﬀectwasgreaterforearly-onset
asthma as compared to late-onset asthma (OR = 5.31 versus
4.05). 58.9% of herbal medications taken by the mothers
during pregnancy belonged to antiabortion herbs (An-Tai-
Yin). We did not observe signiﬁcant relationships between
gestational herbal medication use and childhood asthma.
However, this exposure correlated with early-onset asthma
positively (OR = 3.63; 95%CI, 1.23–10.7) with signiﬁcant
dose responsiveness (P for trend <0.05).
Table 3 shows the impact of birth conditions on child-
hood asthma. Vacuum suction usage during vaginal delivery
signiﬁcantly inﬂuences the odds of asthma (OR = 3.68;
95%, 1.34–10.1). This impact was higher for late-onset
asthma (OR = 5.16; 95% CI, 1.29–20.6). Additionally, being
born before 37 weeks of gestational age was associated with4 Clinical and Developmental Immunology
Table 2: Risks for childhood asthma in relation to gestational medication use.
Controls Ever asthma Early-onset asthma† Late-onset asthma‡
Gestational medication
category N (%)§ N§ OR 95%CI N§ OR 95%CI N§ OR 95%CI
Any medication tablet¶
No 350(90.7) 137 1.00 71 1.00 66 1.00
Yes 36(9.3) 56 3.73 (2.2,6.33)∗∗ 20 3.64 (1.54,8.64)∗ 36 3.90 (1.96,7.75)∗∗
Exposure time
2,3 trimester 19(4.9) 20 1.80 (0.86,3.79) 7 3.37 (0.83, 13.63) 13 1.46 (0.58, 3.70)
1st trimester 17(4.4) 33 6.03 (2.91,12.5)∗∗ 12 3.32 (1.17, 9.43) 21 10.20 (3.34, 31.17)∗∗
Exposure duration
0–6 days 28(7.3) 43 3.46 (1.94,6.17)∗∗ 15 3.41 (1.31, 8.83)∗ 28 3.55 (1.69, 7.45)∗∗
1 week 8(2.1) 13 4.86 (1.77, 13.37)∗ 5 4.57 (0.89, 23.56) 8 5.70 (1.43, 22.77)∗
P for trend <0.001 0.004 <0.001
Medications for common cold
No 351(93.6) 146 1.00 75 1.00 71 1.00
Yes 24(6.4) 41 4.35 (2.28,8.3)∗∗ 13 5.31 (1.63,17.3)∗ 28 4.05 (1.85,8.87)∗∗
Exposure time
2,3 trimester 15(4.0) 17 2.19 (0.97,4.94) 6 4.76 (0.88, 25.90) 11 1.82 (0.67, 4.92)
1st trimester 9(2.4) 21 8.67 (3.10,24.23)∗∗ 6 4.49 (0.82, 24.48) 15 10.20 (2.78, 37.50)∗∗
Exposure duration
0–3 days 16(4.3) 23 3.19 (1.50, 6.79)∗ 8 4.50 (1.19,16.97)∗ 15 2.77 (1.08, 7.14)∗
4 days 8(2.1) 18 7.83 (2.70,22.72)∗∗ 5 8.84 (0.83, 93.83) 13 7.17 (2.16, 23.75)∗
P for trend <0.001 0.008 <0.001
Herbal medication
No 361(93.5) 171 1.00 80 1.00 91 1.00
Yes 25 (6.5) 22 1.59 (0.83,3.05) 11 3.63 (1.23,10.7)∗ 11 1.07 (0.44,2.61)
Exposure time
2,3 trimester 8 (2.3) 8 1.41 (0.48, 4.09) 6 5.17 (0.89, 31.18) 2 0.53 (0.09, 2.95)
1st trimester 15 (4.2) 14 1.94 (0.85, 4.41) 5 2.99 (0.71, 12.54) 9 1.59 (0.57, 4.45)
Exposure duration
<6 days 10 (2.7) 11 1.63 (0.63, 4.23) 7 6.83 (1.22, 38.13) 4 0.65 (0.17, 2.50)
1 week 14 (3.8) 11 1.77 (0.73, 4.28) 4 2.33 (0.58, 9.42) 7 1.96 (0.58, 6.59)
P for trend 0.12 0.05 0.46
Exposure frequency
<3 times/week 19 (5.1) 11 0.82 (0.35,1.94) 6 2.85 (0.68, 12.02) 5 0.41 (0.12, 1.41)
4 times/week 5 (1.4) 10 6.64 (1.89,23.32)∗ 4 4.71 (0.88,25.37) 6 16.70 (1.71, 162.76)
P for trend 0.02 0.02 0.14
Models are adjusted for parental education, mother’s age at birth of her child, parental history of asthma, parental history of atopy, and in utero maternal
smoking.
∗P<0.05; ∗∗P<0.001.
§Number of subjects does not add up to total n because of missing data.
†Early onset: asthma diagnosed 3yrofage.
‡Late onset: asthma diagnosed >3yrofage.
¶Any medication: including any medication tablet that physicians prescribed.
an increased odds of asthma (P for trend <0.05), especially
the early-onset type.
The inﬂuence of early postnatal exposures on childhood
asthmaisoutlinedinTable 4.Exclusivebreastfeedingshowed
a decreased odds of asthma (OR = 0.49; 95% CI, 0.31–
0.79), especially for early-onset asthma (OR = 0.29; 95%CI,
0.13–0.65).Bothrecurrentrespiratorytractinfections(OR =
2.67; 95% CI, 1.78–4.02) and hospitalization in the ﬁrst
year of life (OR = 2.99; 95% CI, 1.58–5.67) were asso-
ciated with increased odds of asthma, especially for early-
onset asthma. Daycare attendance before the child was 3
years old correlated with greater odds of asthma (OR = 2.47;
95%CI,1.33–4.57).However,thisearly-lifeexposureshowed
a greater inﬂuence on late-onset asthma (OR = 4.25; 95%
CI, 1.55–11.7). Moreover, we found that the more children
the caregiver raised in the ﬁrst year life, the higher the
odds of early-onset asthma (OR = 2.04; 95% CI, 1.13–
3.69).Clinical and Developmental Immunology 5
Table 3: Risks for childhood asthma in relation to delivery modes and birth conditions.
Controls Ever asthma Early-onset asthma† Late-onset asthma‡
N (%)§ N§ OR 95%CI N OR 95%CI N§ OR 95%CI
Modes of delivery
Vaginal 255 (66.2) 128 1.00 61 1.00 67 1.00
Scheduled CS 58(15.1) 25 1.04 (0.59, 1.83) 13 1.19 (0.49, 2.88) 12 0.97 (0.45, 2.09)
Emergent CS 72(18.7) 38 1.13 (0.70, 1.83) 16 0.76 (0.37, 1.57) 22 1.63 (0.81, 3.28)
Forceps usage during vaginal
delivery
No 250(98.0) 118 1.00 59 1.00 59 1.00
Yes 5(2.0) 9 2.12 (0.57, 7.91) 2 0.41 (0.04, 3.95) 7 5.10 (0.84, 30.93)
Vacuum usage during vaginal
delivery
No 243(95.3) 103 1.00 51 1.00 52 1.00
Yes 12(4.7) 24 3.68 (1.34, 10.1)∗ 10 2.01 (0.47, 8.63) 14 5.16 (1.29, 20.60)∗
Low birth weight
No 338(90.4) 158 1.00 78 1.00 80 1.00
Yes 36(9.6) 31 1.73 (0.96, 3.1) 13 1.99 (0.77, 5.13) 18 1.76 (0.81, 3.8)
2000–2500gm 25(6.7) 22 1.70 (0.86, 3.35) 9 1.61 (0.56, 4.62) 13 1.60 (0.72, 3.55)
< 2000gm 11(2.9) 9 1.79 (0.66, 4.87) 4 4.18 (0.65, 26.77) 5 5.69 (0.49, 65.67)
P for trend 0.08 0.10 0.09
Preterm delivery¶
No 356(92.2) 169 1.00 80 1.00 89 1.00
Yes 30(7.8) 24 1.83 (0.98, 3.41) 11 2.47 (0.94, 6.50) 13 1.4 (0.63, 3.27)
34–36wk 22(7.2) 16 1.74 (0.81, 3.74) 8 2.51 (0.82, 7.72) 8 1.16 (0.40, 3.36)
< 34wk 2(0.7) 5 4.31 (0.81, 2.88) 3 4.80 (0.44, 52.14) 2 4.48 (0.39, 51.97)
P for trend 0.03 0.04 0.32
Models are adjusted for parental education, mother’s age at birth of her child, parental history of asthma, parental history of atopy, and in utero maternal
smoking.
∗P<0.05.
§Number of subjects does not add up to total n because of missing data.
†Early onset: asthma diagnosed 3yrofage.
‡Late onset: asthma diagnosed >3yrofage.
¶Preterm delivery was deﬁned as children born at gestational age less than 37 weeks.
4. Discussion
Our ﬁndings suggested that the complex etiology of asthma
c o u l db et r a c e db a c kf r o min utero, perinatal to early post-
natal period. In the present case-control study, we found
that childhood asthma was positively related to a series of
early-life events, such as in utero exposure to maternal med-
ication/herbal medication use, vacuum use and being born
before 37 weeks of gestational age during the perinatal pe-
riod, recurrent respiratory tract infections, hospitalization,
and daycareattendance in the early postnatal stage.Exposure
to these factors led to dose responsiveness in the risk of
asthma. Exclusive breastfeeding was negatively related with
childhood asthma. To our knowledge, this is the ﬁrst study
which showed that gestational herbal medication exposures
aﬀected childhood asthma positively. Most of the exposures
revealed a greater impact on early-onset asthma, except for
vacuum use and daycare attendance. These early-life ex-
posures may contribute to the earlier onset of childhood
asthma. Several lines of evidence suggest that children who
will go on to have more severe and persistent asthma symp-
toms already have ﬁrst episode of airway obstruction in their
infancy[13].Hence,inordertopreventthoserelevantfactors
of childhood asthma, it would be important to distinguish
diﬀerentassociatedfactorswhichwillinﬂuenceearly-orlate-
onset of asthma more.
The safety of many common medications used in preg-
nancy has yet to be conﬁrmed. According to a large pro-
spective cohort study, medication use was reported in 39.2%
of pregnancies and herbal medicine use was reported in
0.58% of pregnancies [14]. As compared to studies in
Western countries, our prevalence of gestational medication
use was lower (18.9%), but use of herbal medications during
pregnancy was higher (8.1%). In the present study, we
noted that the majority of medication tablets used during
pregnancy were cold medications. Most cold medications
contain a combination of decongestants, antitussives, expec-
torants, and mild analgesics which include acetaminophen6 Clinical and Developmental Immunology
Table 4: Risks for childhood asthma in relation to early postnatal exposures.
Controls Ever asthma Early-onset asthma† Late-onset asthma‡
Early postnatal exposures N (%)§ N OR 95%CI N OR 95%CI N OR 95%CI
Exclusive breastfeeding
No 268 (69.4) 159 1.00 77 1.00 82 1.00
Yes 118(30.6) 33 0.49 (0.31, 0.79)∗ 13 0.29 (0.13, 0.65)∗ 20 0.67 (0.37, 1.2)
Exclusive BF < 1 month 55 (14.3) 14 0.41 (0.21, 0.77)∗ 7 0.28 (0.10, 0.76)∗ 7 0.49 (0.20, 1.17)
Exclusive BF1 month 63 (16.3) 19 0.60 (0.32, 1.11) 6 0.30 (0.09, 0.95)∗ 13 0.86 (0.41, 1.80)
P for trend 0.01 0.007 0.35
Recurrent respiratory infections¶
No 248(64.6) 79 1.00 33 1.00 46 1.00
Yes 136(35.4) 111 2.67 (1.78, 4.02)∗∗ 56 4.07 (2.01, 8.27)∗∗ 55 2.26 (1.35, 3.81)∗
Frequency
3–6 times/year 91 (23.7) 46 1.55 (0.95, 2.53) 18 1.64 (0.68, 3.96) 28 1.64 (0.90, 3.02)
7 times/year 45 (11.7) 65 5.36 (3.12, 9.22)∗∗ 38 9.42 (3.84, 23.12)∗∗ 27 3.93 (1.86, 8.32)∗∗
P for trend <0.001 <0.001 <0.001
Hospitalization within ﬁrst year of
age
No 362(94.3) 163 1.00 73 1.00 90 1.00
Yes 22(5.7) 30 2.99 (1.58, 5.67)∗∗ 18 4.04 (1.64, 9.96)∗ 12 2.24 (0.86, 5.83)
Frequency
1 times 15(4.3) 23 3.56 (1.68, 7.51)∗ 12 3.53 (1.22, 10.24)∗ 11 3.40 (1.14, 10.10)∗
2 times 5(1.4) 7 2.82 (0.84, 9.53) 6 12.21 (1.30, 115.07)∗ 1 0.62 (0.07, 5.80)
P for trend 0.001 0.002 0.29
Daycare attendance within three
years of age
No 354 (91.7) 161 1.00 74 1.00 87 1.00
Yes 32 (8.3) 30 2.47 (1.33, 4.57)∗ 17 1.77 (0.76, 4.12) 13 4.25 (1.55, 11.7)∗
2-3 years old 17 (4.4) 18 3.12 (1.41, 6.93)∗ 9 1.70 (0.57, 5.03) 9 8.26 (1.94, 35.27)∗
< 2 years old 15 (3.9) 12 1.85 (0.78, 4.40) 8 1.85 (0.59, 5.75) 4 1.90 (0.43, 8.34)
P for trend 0.02 0.20 0.03
Main caregiver cared for other
children
No 231(59.8) 96 1.00 43 1.00 53 1.00
Yes 155(40.2) 97 1.51 (1.02, 2.23)∗ 48 2.04 (1.13, 3.69)∗ 49 1.13 (0.65, 1.97)
Number of children||
1 108(27.9) 67 1.42 (0.92, 2.20) 33 2.02 (1.04, 3.92)∗ 34 1.01 (0.55, 1.86)
2 47(12.1) 30 1.73 (0.97, 3.08) 15 2.10 (0.87, 5.06) 15 1.48 (0.67, 3.29)
P for trend 0.04 0.03 0.42
Models are adjusted for parental education, mother’s age at birth of her child, parental history of asthma, parental history of atopy, in utero maternal smoking.
∗P<0.05; ∗∗P<0.001.
§Number of subjects does not add up to total n because of missing data.
†Early onset: asthma diagnosed 3yrofage.
‡Late onset: asthma diagnosed >3yrofage.
¶Recurrent respiratory infections were deﬁned as more than three times of respiratory infections in the ﬁrst year of life.
||The number of other children the main caregiver cared for in the ﬁrst year of life.
BF: breastfeeding.
and nonsteroidal anti-inﬂammatory drugs (NSAIDs) [15].
Many studies have shown that prenatal exposure to acetam-
inophen may increase the risk of asthma, which was com-
patible with our ﬁndings with regards to cold medication
use (Table 2). The possible mechanism of the association
between acetaminophen and asthma has been hypothesized
to involve the glutathione pathway which is downregulated
following acetaminophen exposure [16].
The use of herbal medicine during the pregnancy period
iscommoninTaiwan[9].Wesurveyedsomeofthecommon-
ly used herbal medications in Taiwan, such as Bazhen Tang,
Si Wu Tang, Ginseng, Coptis root, antiabortion herbs (An-
Tai-Yin). Bazhen Tang and Si Wu Tang are used for better
growth in fetus weight. Ginseng is used to avoid abortion in
the early stage of pregnancy. Coptis root is taken to solve the
skinproblemsofpregnantwomenandtoenhancethebeautyClinical and Developmental Immunology 7
of the skin of infants. An-Tai-Yin is used in pregnant women
under risk of abortion to avoid abortion of fetus. We found
that more than half of the herbal medications taken by the
mothers during pregnancy belonged to antiabortion herbs
(An-Tai-Yin). In a previous Taiwanese study, it was reported
that An-Tai-Yin use during the ﬁrst trimester was associated
with an increased risk of congenital malformations of the
musculoskeletal and connective tissues [17]. Until now, no
study has been conducted on the relationships between
gestational herbal medication use and asthma. In our study,
we found that gestational herbal medication use was signiﬁ-
cantly associated with increased odds of early-onset asthma.
Themorefrequenttheherbalmedicationusebymothers,the
highertheriskofasthmafortheirchildren(Table 2).Because
of the incompletely assessed safety and eﬃcacy of herbal
medications,avoidanceofherbalmedicineduringpregnancy
should be recommended by obstetricians [18].
Reports on the relationships between cesarean section
(CS) and childhood asthma are not consistent [4, 19]. “Hy-
giene hypothesis” suggested that the sterile infant is colo-
nized by bacteria from the hospital environment and skin,
not by maternal bacteria from the birth canal and perineum.
Therefore, the initial “wrong” microbes can have long-term
adverse eﬀects on triggering atopic diseases [4]. Another
possible mechanism is that CS is associated with increased
risk of newborn respiratory distress syndrome, which might
predispose to childhood asthma. Contrary to other studies
[20], our result did not reveal a signiﬁcant relationship be-
tween CS and childhood asthma. The results of this study
were not consistent with the “hygiene hypothesis” and sug-
gested that there might be a complex interaction between
host and microbial agents with heterogeneous eﬀects on the
development of asthma [19].
Inourdata,vacuum-assisteddeliverywasassociatedwith
childhoodasthma(Table 3),whichwasconsistentwithmany
previous studies [21]. Vacuum delivery is commonly indi-
cated for prolong labor, maternal exhaustion, or emergencies
at the delivery process. Maternal stress is related to excessive
cortisol secretion, which further aﬀects the child’s immune
system and increases the child’s susceptibility to allergic
disease [22]. In certain emergent circumstances, vacuum-
assisted suction would be used in removing meconium as-
piration, which could cause damage in lung of an infant.
This pathological damage might lead the child to be more
susceptible to having asthma in the future [23]. On the other
hand, we found an inverse association between gestational
age and childhood asthma, especially early-onset asthma.
Our result was consistent with one recent meta-analysis
based on 19 studies showing that children born prematurely
would have an approximately 7% higher risk of asthma as
compared with full-term children [5]. Another large pop-
ulation-based study suggested that this association was not
solely due to prematurity increasing the risk of respiratory
tract infection [24]. The exact mechanisms behind the links
between preterm delivery and the development of childhood
asthma need further investigation.
We found that exclusive breastfeeding prevents chil-
dren from having asthma, especially for early-onset asthma
(Table 4). The mechanisms for the eﬀect of breastfeeding to
protect infants from atopic diseases are quite complex. One
isthatsolubleTGF-β,whichispredominantinhumanbreast
milk,increasestheabilityoftheinfanttoproduceIgAagainst
allergens. Soluble CD 14 in breast milk is thought to be the
induction of a Th1 response to bacteria [25]. Another pos-
sible mechanism is related to childhood exposure to mi-
crobes. Breast milk may provide antiviral antibodies and
other factors that reduce the incidence of these infections
and subsequent wheezing. In a multicountry meta-analysis,
breastfeeding was found to protect against only nonatopic
wheezing in nonaﬄuent countries with OR of 0.69 (95%
CI, 0.53–0.90) [26]. However, in another cluster random-
ized trial, results did not support the protective eﬀect of
prolonged and exclusive breastfeeding on childhood asthma
[27]. Although our retrospective study design is prone to
suﬀer from recall bias, it has been proven that maternal recall
isvalidandreliableinestimatingbreastfeedinginitiationand
duration [28]. Further extensive studies on the diﬀerences of
mechanisms between exclusive and nonexclusive breastfeed-
ing in relation to childhood asthma are warranted.
Exposures to recurrent respiratory tract infections and
hospitalization in the ﬁrst year of life were associated with
increased odds of early-onset asthma. (Table 4) Early daycare
would result in more respiratory infections early in life [7].
Infections with respiratory syncytial virus (RSV), parain-
ﬂuenza, inﬂuenza, and rhinovirus are closely associated with
the development of wheezing and pulmonary inﬂammation
[29]. RSV-associated respiratory tract infections represented
the most common cause of hospitalization at early infancy.
Infact,numerousstudiesreportedassociationsbetweenRSV
bronchiolitis in early childhood and recurrent wheezing and
asthma in later childhood [30]. Our ﬁndings were consistent
with these studies, but disputed the “hygiene hypothesis”,
suggesting the protective role of microbial infections during
early childhood with regards to the development of asthma.
Epidemiologic studies have challenged the “hygiene hypoth-
esis” as being oversimpliﬁed [31]. One recent in vivo study
suggested that innate immune stimulation via microbes
could cause allergen sensitization in a dose- and time-de-
pendent manner [32]. There might be complicated interac-
tions between host and microbial agents in asthma develop-
ment.
Recall bias is the major limitation in any case-control
design. The mothers of children in the present study were
informed that the interview was about the children’s health
problems, instead of explicitly mentioning asthma initially.
Identiﬁcation of asthma was performed at the end of the
interviewtoreducethepossibilityofrecallbias.Distantrecall
of prenatal and perinatal factors reported by biological
mothers has been considered a reliable approach in previous
studies [33–35]. Githens et al. found 102 usable and reliable
responses from mothers concerning gestational, perinatal
and early-postnatal factors with a recall period of four to
six years [35]. Yawn et al. also reported a high degree of
agreement between medical records and maternal report
for perinatal events such as cesarean section, preexisting
diabetes, and smoking in a 10 to 15 years distant recall [33].
Moreover, in Buka et al.’s retrospective survey, women can
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andlengthofgestationevenafter22years[34].Furthermore,
early-life environmental exposures in this study were not all
well-known risk factors for childhood asthma, such as gesta-
tional medication use, herbal medication use, and vacuum
delivery. The probability of a mother mistakenly recalling
the early-life events during her pregnancy such as gestational
medication use and her child’s life should be comparable
in both case and control groups, and a misclassiﬁcation is
likely to be nondiﬀerential [36]. Moreover, signiﬁcant dose
responsiveness in many early-life exposures conﬁrmed the
importance of these risk factors. We believe that it is unlikely
that a mother would have recall bias about the breastfeeding,
hospitalization, and daycare attendance of her child [28, 37].
Given the rise in telephone scams in Taiwan today, the more
educated mother in the healthy group tended to decline
any telephone interviews from people they do not already
personally know. Selection bias may exist in telephone in-
terview process because less educated mothers in the control
groups may be more willing to be interviewed. On the
contrary,well-educatedmothersofasthmaticchildrenwould
be more willing to answer our 30 minutes telephone inter-
view, because they cared about their child’s health more. To
compensate for this, we adjusted the level of education of
the parents in our statistical models. On the other hand,
we noticed that those mothers in our control group were of
lower in utero smoking prevalence. This is because mothers
whoarewillingtoanswerourtelephoneinterviewwerethose
who cared about their children’s health more. Therefore, in
utero maternal smoking was chosen was a confounder to be
adjusted in our statistical model.
5. Conclusions
Our data disclosed that gestational medication use, vacuum
delivery, recurrent respiratory tract infections, hospitaliza-
tion, and daycare attendance in early postnatal stage were
associated with higher odds of childhood asthma. Exclusive
breastfeeding protects children from asthma. Most of the
exposures revealed a greater impact on early-onset asthma,
except for vacuum use and daycare attendance. We recom-
mend that mothers should be encouraged to breastfeed, to
avoid any unnecessary medication during their pregnancy,
and to protect children from harmful exposures in their early
childhood.
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